Need help finding what you are looking for?
Contact Us
PUBLISHER: BCC Research | PRODUCT CODE: 1813330
PUBLISHER: BCC Research | PRODUCT CODE: 1813330
AI in Biotechnology: Global Markets
PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global market for AI in biotechnology was valued at $3.8 billion in 2024. The market is estimated to grow from $4.6 billion in 2025 to $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 20% from 2025 to 2030.
The North American market for AI in biotechnology is estimated to grow from $2.7 billion in 2025 to $7 billion by 2030, at a CAGR of 20.6% from 2025 to 2030.
The Asia-Pacific market for AI in biotechnology is estimated to grow from $587.9 million in 2025 to $1.7 billion by 2030, at a CAGR of 23.4% from 2025 to 2030.
Report Scope
The report analyzes the trends in the global market for AI in biotechnology. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented by product type (software and services), deployment (cloud-based and on-premises), application and end user. Applications consist of drug discovery, clinical trials, diagnostics and others. End users consist of pharmaceutical and biotech companies, academic research institutes, contract R&D organizations (CROs/CDMOs) and others. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the Rest of Europe, China, Japan, India, South Korea and the Rest of Asia-Pacific.
The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. It offers company profiles that covers such details as financials, product portfolio and recent developments. It analyzes companies' environmental, social and corporate governance (ESG) initiatives.
Report Includes
- 50 data tables and 57 additional tables
- An analysis of the current and future global markets for artificial intelligence (AI) in biotechnology
- Analyses of the global market trends, with historic revenue data (sales figures) from 2022 to 2024, estimates for 2025, and projected CAGRs through 2030
- Estimates of the size of the market and revenue prospects, along with a corresponding market share analysis based on product type, application, deployment type, end user, and region
- Facts and figures pertaining to market dynamics, technological advancements, regulations, prospects and the impact of macroeconomic variables
- Discussion of the underlying opportunities and potential, with the development of novel products, drug discovery, clinical trials and other related applications
- Insights derived from Porter's Five Forces model and global supply chain analyses
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
- Profiles of the leading companies, including NVIDIA Corp., Tempus AI Inc., Recursion Pharmaceuticals, Schrodinger Inc., and Sophia Genetics
Product Code: AIT016A
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
- Overview
- Current Market Scenario
- Segmental Analysis
- Regional Market Insights
- Emerging Technologies
- Conclusion
Chapter 2 Market Overview
- Overview
- Potential Applications of AI in Biotechnology
- Use Cases
- Use Case 1: Drug Discovery
- Use Case 2: Personalized Medicine
- AI's Impact on the Biotech Value Chain
- Macroeconomic Factors Analysis
- Demographic Factors
- Geopolitical Factors
- Impact of U.S. Tariffs
- Porter's Five Forces Analysis
Chapter 3 Market Dynamics
- Market Dynamics
- Market Drivers
- Need for More Effective Drug Discovery and Development Process
- Shift to Personalized Medicine
- Growing Demand for Effective and Early Diagnosis
- Rising Investments in AI in Biopharmaceuticals
- Aging Population and the Growing Prevalence of Chronic Diseases
- Market Restraints
- Data Quality and Bias
- Integration Hurdles
- Ethical Concerns
- Market Opportunities
- AI in Synthetic Biology
- Convergence of AI and Quantum Computing
Chapter 4 Regulatory Landscape
- Regulatory Scenario
- United States
- Europe
- Asia-Pacific
Chapter 5 Emerging Technologies and Developments
- Emerging Trends/Technologies
- Key Takeaways
- Agentic AI
- Generative AI
- Federated Learning
- Advanced Neural Networks
Chapter 6 Market Segmentation Analysis
- Overview
- Segmentation Breakdown
- Market Analysis by Product Type
- Key Takeaways
- Software
- Services
- Market Analysis by Deployment Type
- Key Takeaways
- Cloud-based
- On-premises
- Market Analysis by Application
- Key Takeaways
- Drug Discovery
- Clinical Trials and Optimization
- Diagnostics
- Other Applications
- Market Analysis by End User
- Key Takeaways
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
- Contract Manufacturing and Development Organizations
- Other End Users
- Geographic Breakdown
- Market Analysis by Region
- Key Takeaways
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 Competitive Intelligence
- Key Takeaways
- Competitive Analysis
- Strategic Initiatives
- Mergers and Acquisitions
- Agreements, Collaborations and Partnerships
- Investment Landscape
Chapter 8 Sustainability in AI in Biotechnology Market: An ESG Perspective
- Introduction to ESG
- Sustainability Trends and Company Initiatives
- ESG Risk Ratings
- Concluding Remarks
Chapter 9 Appendix
- Research Methodology
- Sources
- Abbreviations
- Company Profiles
- ABCELLERA BIOLOGICS INC.
- ABSCI CORP.
- ATOMWISE INC.
- BENEVOLENTAI
- DNANEXUS INC.
- EUROFINS SCIENTIFIC
- ILLUMINA INC.
- INSILICO MEDICINE
- NVIDIA CORP.
- QIAGEN
- RECURSION
- SCHRODINGER INC.
- SOPHIA GENETICS
- TEMPUS AI INC.
- XTALPI INC.
- Other Emerging Companies in the Market
Product Code: AIT016A
List of Tables
- Summary Table : Global Market for AI in Biotechnology, by Region, Through 2030
- Table 1 : Applications of AI in Biotechnology
- Table 2 : Global Incidence and Mortality Cancer Rates, by WHO Region, 2022
- Table 3 : Global Market for AI in Biotechnology, by Product Type, Through 2030
- Table 4 : Software Platforms
- Table 5 : Global Market for AI Software in Biotechnology, by Region, Through 2030
- Table 6 : Global Market for AI in Biotechnology Services, by Region, Through 2030
- Table 7 : Global Market for AI in Biotechnology, by Deployment, Through 2030
- Table 8 : Global Market for Cloud Deployments for AI in Biotechnology, by Region, Through 2030
- Table 9 : Global Market for On-Premises Deployments for AI in Biotechnology, by Region, Through 2030
- Table 10 : Global Market for AI in Biotechnology, by Application, Through 2030
- Table 11 : Global Market for AI in Biotechnology for Drug Discovery, by Region, Through 2030
- Table 12 : Global Market for AI in Biotechnology for Clinical Trials and Optimization, by Region, Through 2030
- Table 13 : Global Market for AI in Biotechnology for Diagnostics, by Region, Through 2030
- Table 14 : Global Market for AI in Biotechnology for Other Applications, by Region, Through 2030
- Table 15 : Global Market for AI in Biotechnology, by End User, Through 2030
- Table 16 : Global Market for AI in Biotechnology for Pharma and Biotech Companies, by Region, Through 2030
- Table 17 : Global Market for AI in Biotechnology for Academic Research Institutes, by Region, Through 2030
- Table 18 : Global Market for AI in Biotechnology for Contract Organizations, by Region, Through 2030
- Table 19 : Global Market for AI in Biotechnology for Other End Users, by Region, Through 2030
- Table 20 : Global Market for AI in Biotechnology, by Region, Through 2030
- Table 21 : North American Market for AI in Biotechnology, by Product Type, Through 2030
- Table 22 : North American Market for AI in Biotechnology, by Deployment, Through 2030
- Table 23 : North American Market for AI in Biotechnology, by Application, Through 2030
- Table 24 : North American for AI in Biotechnology, by End User, Through 2030
- Table 25 : North American Market for AI in Biotechnology, by Country, Through 2030
- Table 26 : European Market for AI in Biotechnology, by Product Type, Through 2030
- Table 27 : European Market for AI in Biotechnology, by Deployment, Through 2030
- Table 28 : European Market for AI in Biotechnology, by Application, Through 2030
- Table 29 : European Market for AI in Biotechnology, by End User, Through 2030
- Table 30 : European Market for AI in Biotechnology, by Country, Through 2030
- Table 31 : Asia-Pacific Market for AI in Biotechnology, by Product Type, Through 2030
- Table 32 : Asia-Pacific Market for AI in Biotechnology, by Deployment, Through 2030
- Table 33 : Asia-Pacific Market for AI in Biotechnology, by Application, Through 2030
- Table 34 : Asia-Pacific Market for AI in Biotechnology, by End User, Through 2030
- Table 35 : Asia-Pacific Market for AI in Biotechnology, by Country, Through 2030
- Table 36 : RoW Market for AI in Biotechnology, by Product Type, Through 2030
- Table 37 : RoW Market for AI in Biotechnology, by Deployment, Through 2030
- Table 38 : RoW Market for AI in Biotechnology, by Application, Through 2030
- Table 39 : RoW Market for AI in Biotechnology, by End User, Through 2030
- Table 40 : RoW Market for AI in Biotechnology, by Sub-Region, Through 2030
- Table 41 : Global Ranking of Companies in the Market for AI in Biotechnology, 2024
- Table 42 : M&A in the AI in Biotechnology Industry, 2024-2025
- Table 43 : Agreements and Partnerships in the Market for AI in Biotechnology, 2023-2025
- Table 44 : Total Funding for AI Biotech Companies
- Table 45 : ESG Risk Ratings of Companies in AI Biotechnology Market, 2024
- Table 46 : Information Sources Used for this Report
- Table 47 : Abbreviations Used in this Report
- Table 48 : AbCellera Biologics Inc.: Company Snapshot
- Table 49 : AbCellera Biologics Inc.: Financial Performance, FY 2023 and 2024
- Table 50 : AbCellera Biologics Inc.: Product Portfolio
- Table 51 : AbCellera Biologics Inc.: News/Key Developments, 2023-2025
- Table 52 : Absci Corp.: Company Snapshot
- Table 53 : Absci Corp.: Financial Performance, FY 2023 and 2024
- Table 54 : Absci Corp.: Product Portfolio
- Table 55 : Absci Corp.: News/Key Developments, 2023-2025
- Table 56 : Atomwise Inc.: Company Snapshot
- Table 57 : Atomwise Inc.: Product Portfolio
- Table 58 : Atomwise Inc.: News/Key Developments, 2022
- Table 59 : BenevolentAI: Company Snapshot
- Table 60 : BenevolentAI: Financial Performance, FY 2022 and 2023
- Table 61 : BenevolentAI: Product Portfolio
- Table 62 : BenevolentAI: News/Key Developments, 2022-2024
- Table 63 : DNAnexus Inc.: Company Snapshot
- Table 64 : DNAnexus Inc.: Product Portfolio
- Table 65 : DNAnexus Inc.: News/Key Developments, 2024-2025
- Table 66 : Eurofins Scientific: Company Snapshot
- Table 67 : Eurofins Scientific: Financial Performance, FY 2023 and 2024
- Table 68 : Eurofins Scientific: Product Portfolio
- Table 69 : Eurofins Scientific: News/Key Developments, 2024
- Table 70 : Illumina Inc.: Company Snapshot
- Table 71 : Illumina Inc.: Financial Performance, FY 2023 and 2024
- Table 72 : Illumina Inc.: Product Portfolio
- Table 73 : Illumina Inc.: News/Key Developments, 2023-2025
- Table 74 : Insilico Medicine: Company Snapshot
- Table 75 : Insilico Medicine: Product Portfolio
- Table 76 : Insilico Medicine: News/Key Developments, 2023-2025
- Table 77 : Nvidia Corp.: Company Snapshot
- Table 78 : Nvidia Corp.: Financial Performance, FY 2023 and 2024
- Table 79 : Nvidia Corp.: Product Portfolio
- Table 80 : Nvidia Corp.: News/Key Developments, 2023-2025
- Table 81 : Qiagen: Company Snapshot
- Table 82 : Qiagen: Financial Performance, FY 2023 and 2024
- Table 83 : Qiagen: Product Portfolio
- Table 84 : Qiagen: News/Key Developments, 2025
- Table 85 : Recursion: Company Snapshot
- Table 86 : Recursion: Financial Performance, FY 2023 and 2024
- Table 87 : Recursion: Product Portfolio
- Table 88 : Recursion: News/Key Developments, 2024-2025
- Table 89 : Schrodinger Inc.: Company Snapshot
- Table 90 : Schrodinger Inc.: Financial Performance, FY 2023 and 2024
- Table 91 : Schrodinger Inc.: Product Portfolio
- Table 92 : Schrodinger Inc: News/Key Developments, 2023-2024
- Table 93 : Sophia Genetics: Company Snapshot
- Table 94 : Sophia Genetics: Financial Performance, FY 2023 and 2024
- Table 95 : Sophia Genetics: Product Portfolio
- Table 96 : Sophia Genetics: News/Key Developments, 2025
- Table 97 : Tempus AI Inc.: Company Snapshot
- Table 98 : Tempus AI Inc.: Financial Performance, FY 2023 and 2024
- Table 99 : Tempus AI Inc.: Product Portfolio
- Table 100 : Tempus AI Inc.: News/Key Developments, 2023-2025
- Table 101 : XtalPi Inc.: Company Snapshot
- Table 102 : XtalPi Inc.: Financial Performance, FY 2023 and 2024
- Table 103 : XtalPi Inc.: Product Portfolio
- Table 104 : XtalPi Inc.: News/Key Developments, 2024 and 2025
- Table 105 : Other Companies in the Market for AI in Biotechnology
- Table 106 : Emerging Startups in the AI in Biotechnology Market
List of Figures
- Summary Figure : Global Market Shares of AI in Biotechnology, by Region, 2024
- Figure 1 : Potential Applications of AI in Biotechnology
- Figure 2 : Impact of AI on the Biotechnology Value Chain
- Figure 3 : Porter's Five Forces Analysis of the AI in Biotechnology Industry
- Figure 4 : Snapshot of AI in Biotechnology Market Dynamics
- Figure 5 : Emerging AI Technologies in the Biotechnology Market
- Figure 6 : Global Market Shares of AI in Biotechnology, by Product Type, 2024
- Figure 7 : Global Market Shares of AI in Biotechnology, by Deployment, 2024
- Figure 8 : Global Market Shares of AI in Biotechnology, by Application, 2024
- Figure 9 : Global Market Shares of AI in Biotechnology, by End User, 2024
- Figure 10 : Global Market Shares of AI in Biotechnology, by Region, 2024
- Figure 11 : North American Market Shares of AI in Biotechnology, by Country, 2024
- Figure 12 : European Market Shares of AI in Biotechnology, by Country, 2024
- Figure 13 : Asia-Pacific Market Shares of AI in Biotechnology, by Country, 2024
- Figure 14 : RoW Market Shares of AI in Biotechnology, by Sub-Region, 2024
- Figure 15 : Investments in Biopharma AI Companies, 2019-2024
- Figure 16 : Market Shares of AI Biotech Startup Investment Landscape, by Funding, 2024
- Figure 17 : AbCellera Biologics Inc: Revenue Share, by Business Unit, FY 2024
- Figure 18 : AbCellera Biologics Inc: Revenue Share, by Country/Region, FY 2024
- Figure 19 : BenevolentAI: Revenue Share, by Country/Region, FY 2024
- Figure 20 : Eurofins Scientific: Revenue Share, by Business Unit, FY 2024
- Figure 21 : Eurofins Scientific: Revenue Share, by Country/Region, FY 2024
- Figure 22 : Illumina Inc.: Revenue Share, by Business Unit, FY 2024
- Figure 23 : Illumina Inc.: Revenue Share, by Country/Region, FY 2024
- Figure 24 : Nvidia Corp.: Revenue Share, by Business Unit, FY 2024
- Figure 25 : Nvidia Corp.: Revenue Share, by Country/Region, FY 2024
- Figure 26 : Qiagen: Revenue Share, by Business Unit, FY 2024
- Figure 27 : Qiagen: Revenue Share, by Country/Region, FY 2024
- Figure 28 : Schrodinger Inc.: Revenue Share, by Business Unit, FY 2024
- Figure 29 : Schrodinger Inc: Revenue Share, by Country/Region, FY 2024
- Figure 30 : Sophia Genetics: Revenue Share, by Business Unit, FY 2024
- Figure 31 : Sophia Genetics: Revenue Share, by Country/Region, FY 2024
- Figure 32 : Tempus AI Inc.: Revenue Share, by Business Unit, FY 2024
- Figure 33 : XtalPi Inc.: Revenue Share, by Business Unit, FY 2024
- Figure 34 : XtalPi Inc.: Revenue Share, by Country/Region, FY 2024
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.